Arthur Bueno on Thu, 16 Sep 1999 18:54:17 +0200 |
[Date Prev] [Date Next] [Thread Prev] [Thread Next] [Date Index] [Thread Index]
Syndicate: XANAX PLACEBO |
Date: Thu, 16 Sep 1999 01:29:44 -0800 From: /m/e/t/a/ <meta@null.net> Xanax Tablets contain alparzolam which is a triazolo analog of the 1,4-benzodiazepine class of central nervous system-active compounds. The chemical name of alprazolam is 8-Chloro-1-methyl-6-phenyl-4H-s-triazolo [4,3-alpha][1,4]benzodiazepine. Inactive ingredients: Cellulose, corn starch, docusate sodium, lactose, magnesium strearate, silicon dioxide and sodium benzoate. In addition, the 0.5 mg tablet contains FD& C Yellow No. 6 and the 1 mg tablet contains FD& C Blue No. 2. 09/13/99 DG DISPATCH - EFNS: Depression Commonly Misdiagnosed As Dementia Early Treatment Improves HIV-Related Dementia 09/09/99 Attenade Effective In the Treatment Of ADD And ADHD Communication Training, Drug Therapy Combination Greatly Reduces Self-Injury 08/31/99 Alcohol Researchers Identify Medication That Lessens Relapse Risk 08/18/99 IPA MEETING: Aricept Effective In Long-Term Treatment Of Alzheimer's 08/17/99 IPA CONGRESS: Aricept Effective, Well-Tolerated For Long-Term Alzheimer's Treatment 08/10/99 PSYCHIATRY CONGRESS: Seroquel Effective Treatment For Schizophrenia In Partial Responders 08/06/99 PSYCHIATRY CONGRESS: Paxil Effective Treatment For Social Anxiety Disorder 08/03/99 Boys Treated With Stimulants Less Likely To Abuse Drugs As Adults 08/02/99 Chronic, Heavy Cocaine Use Associated With Long-Lasting Impaired Function ISP CONGRESS: Zyprexa Reduces Hyperprolactinemia Prevalence In Schizophrenia Patients 07/12/99 Neurontin Reduces Symptoms Of Social Phobia Discontinuation-Emergent Symptom Incidence Percentage of 641 Xanax-Treated Panic Disorder Patients Reporting Events Body System/Event Neurologic Gastrointestinal Insomnia 29.5 Nausea/Vomiting 16.5 Lightheadedness 19.3 Diarrhea 13.6 Abnormal involuntary Decreased salivation 10.6 movement 17.3 Headache 17.0 Metabolic-Nutritional Muscular twitching 6.9 Weight loss 13.3 Impaired Coordination 6.6 Decreased appetite 12.8 Muscle tone disorders 5.9 Weakness 5.8 Dermatological Psychiatric Sweating 14.4 Anxiety 19.2 Fatigue and Tiredness 18.4 Cardiovascular Irritability 10.5 Tachycardia 12.2 Cognitive disorder 10.3 Memory impairment 5.5 Special Senses Depression 5.1 Blurred vision 10.0 Confusional state 5.0 07/05/99 Clozapine May Restore Information Processing To Schizophrenia Patients 06/29/99 Depression In Breast Cancer Patients Linked To Lack Of Estrogen For Heart Disease Patients, Depression Takes Heavy Toll Once-Daily Adderall As Effective As Twice Daily For ADHD 06/25/99 DG DISPATCH - HEADACHE: Sumatriptan Non-Responders Often Have Other Personality Disorders 06/21/99 ADA MEETING: Diabetes and Depression Enhance Each Other's Severity and Cost 06/18/99 Zyprexa Reduces Symptoms Of Mania, Severe Depression In Bipolar Disorder 06/17/99 BIPOLAR DISORDERS MEETING: Researchers Find New Approach To Treating Bipolar Disorder DG DISPATCH - ENDO 99: Anorexia Nervosa Linked To Serious Bone Loss Youth Stress Key Predictor Of Later Hypertension 06/02/99 Neotrofin Effective In Alzheimer's Disease Treatment 05/28/99 DG DISPATCH - APA MEETING: Cognitive Improvement Associated With Olanzapine 05/27/99 DG DISPATCH - APA MEETING: Combination Treatment Often Necessary For Bipolar Disorder DG DISPATCH - APA MEETING: HIV Infection Associated With Psychiatric Symptoms DG DISPATCH - APA MEETING: Overview Of Treatment For Bipolar Disorder 05/25/99 AGS MEETING: ProMem Improves Symptoms Of Alzheimer's Low Cholesterol Levels May Be Linked To Depression, Anxiety Smoking And Depression Weakens Immune System 05/21/99 APA MEETING: Seroquel Improves Psychotic Symptoms Of Alzheimer's, Parkinson's Diseases Anxiety Disorders Incidence of Intervention Treatment-Emergent Because of Symptom Incidence(1) Symptom XANAX PLACEBO XANAX Number of Patients 565 505 565 % of Patients Reporting: CENTRAL NERVOUS SYSTME Drowsiness 41.0 21.6 15.1 Lightheadedness 20.8 19.3 1.2 Depression 13.9 18.1 2.4 Headache 12.9 19.6 1.1 Confusion 9.9 10.0 0.9 Insomnia 8.9 18.4 1.3 Nervousness 4.1 10.3 1.1 Syncope 3.1 4.0 * Dizziness 1.8 0.8 2.5 Akathisia 1.6 1.2 * Tiredness/Sleepiness * * 1.8 GASTOINTESTINAL Dry Mouth 14.7 13.3 0.7 Constipation 10.4 11.4 0.9 Diarrhea 10.1 10.3 1.2 Nausea/Vomiting 9.6 12.8 1.7 Increased Salivation 4.2 2.4 * CARDIOVASCULAR Tachycardia/Palpitations 7.7 15.6 0.4 Hypotension 4.7 2.2 * SENSORY Blurred Vision 6.2 6.2 0.4 MUSCULOSKELETAL Rigidity 4.2 5.3 * Tremor 4.0 8.8 0.4 CUTANEOUS Dermatitis/Allergy 3.8 3.1 0.6 OTHER Nasal Congestion 7.3 9.3 * Weight Gain 2.7 2.7 * Weight Loss 2.3 3.0 * Notes: * None reported (1) Events reported by 1% or more of Xanax patients are included. 05/20/99 APA MEETING: Seroquel Appears To Work In Some Bipolar And Schizoaffective Patients 05/19/99 APA MEETING: Effexor Produces Superior Remission Rates To SSRIs APA MEETING: Effexor XR Produces Significant Relief From Depression In First Week of Treatment APA MEETING: Once-Daily Adderall More Effective Than Ritalin For ADHD 05/18/99 APA MEETING: Drug-Psychotherapy Combo Effective For Chronic Depression APA MEETING: Early Response To Zoloft Indicative Of Future Success In Panic Disorder Treatment Prozac Tablet To Be Available In The U.S. June 1, 1999 Reboxetine Effective In Treating Depression Symptoms 05/17/99 APA MEETING: Electromagnetic Stimulation Shows Promise For Treatment-Resistant Depression APA MEETING: Zaleplon Effective Against Insomnia Without Residual Effects Greater Orgasm Dysfunction Found In Patients Taking Zoloft Than Wellbutrin SR 05/14/99 SBP MEETING: Risperdal Significantly Decreases Schizophrenia Relapse Risk 05/13/99 Researchers Look To Omega-3 Fatty Acid For Manic Depression Treatment Study Shows Psychotherapy As Effective As Drug Therapy For Atypical Depression 05/11/99 Adolescent Depression Often Continues To Adulthood FDA Approves Paxil In The U.S. For Social Anxiety Disorder 05/06/99 Paxil Approved In Canada For Social Anxiety Disorder 05/03/99 Newest Depression Treatments Widely Prescribed For Children 04/30/99 Luvox Effective For Treating Social Phobia 04/28/99 AANS MEETING: Study Shows Depression In Brain Tumor Patients May Go Untreated 04/26/99 DG DISPATCH - AAN: Autism Linked To Smaller Volumes In Hippocampus And Amygdala DG DISPATCH - AAN: Metifronate Improves Psychiatric Profile Of Patients With Alzheimer's Disease 04/21/99 Risperdal Improves Learning Capacity, Skills Acquisition For Schizophrenia Patients 04/20/99 DG Dispatch - AAN: Significant Differences Found In Male And Female Brains 04/19/99 Ampalex Produces Cognition Improvement In Schizophrenia Patients DG Dispatch - AAN: Differences In Brain Size Found In Hyperactive Children Panic Disorder Treatment-Emergent Symptom Incidence* XANAX PLACEBO Number of Patients 1388 1231 % of Patients Reporting: CENTRAL NERVOUS SYSTEM Drowsiness 76.8 42.7 Fatigue and Tiredness 48.6 42.3 Impaired Coordination 40.1 17.9 Irritability 33.1 30.1 Memory Impairment 33.1 22.1 Lightheadedness/Dizziness 29.8 36.9 Insomnia 29.4 41.8 Headache 29.2 35.6 Cognitive Disorder 28.8 20.5 Dysarthria 23.3 6.3 Anxiety 16.6 24.9 Abnormal Involuntary Movement 14.8 21.0 Decreased Libido 14.4 8.0 Depression 13.8 14.0 Confusional State 10.4 8.2 Muscular Twitching 7.9 11.8 Increased Libido 7.7 4.1 Change in Libido (Not Specified) 7.1 5.6 Weakness 7.1 8.4 Muscle Tone Disorders 6.3 7.5 Syncope 3.8 4.8 Akathisia 3.0 4.3 Agitation 2.9 2.6 Disinhibition 2.7 1.5 Paresthesia 2.4 3.2 Talkativeness 2.2 1.0 Vasomotor Disturbances 2.0 2.6 Derealization 1.9 1.2 Dream Abnormalities 1.8 1.5 Fear 1.4 1.0 Feeling Warm 1.3 0.5 GASTROINTESTINAL Decreased Salivation 32.8 34.2 Constipation 26.2 15.4 Nausea/Vomiting 22.0 31.8 Diarrhea 20.6 22.8 Abdonimal Distress 18.3 21.5 Increased Salivation 5.6 4.4 CARDIO-RESPIRATORY Nasal Congestion 17.4 16.5 Tachycardia 15.4 26.8 Chest Pain 10.6 18.1 Hyperventilation 9.7 14.5 Upper Respiratory Infection 4.3 3.7 SENSORY Blurred Vision 21.0 21.4 Tinnitus 6.6 10.4 MUSCULOSKELETAL Muscular Cramps 2.4 2.4 Muscle Stiffness 2.2 3.3 CUTANEOUS Sweating 15.1 23.5 Rash 10.8 8.1 OTHER Increased Appetite 32.7 22.8 Decreased Appetite 27.8 24.1 Weight Gain 27.2 17.9 Weight Loss 22.6 16.5 Micturition Difficulties 12.2 8.6 Menstrual Disorders 10.4 8.7 Sexual Dysfunction 7.4 3.7 Edema 4.9 5.6 Incontinence 1.5 0.6 Infection 1.3 1.7 Note: * Events reported by 1% or more of Xanax patients are included. 04/08/99 Genetic, Familial Factors Influence ADHD 04/05/99 Adderall As Effective, Longer-Lasting Than Ritalin For ADHD 03/26/99 ADAA MEETING: Effexor XR Effective In Treating Symptoms Of Generalised Anxiety Disorder 03/24/99 SSRI Antidepressants Effective In Young Patients With Body Dysmorphic Disorder 03/23/99 ACS MEETING: Improved Ritalin Offers Smaller Doses And Fewer Side Effects SGO MEETING: Women With Ovarian Cancer Have Higher Rates Of Depression, Anxiety 03/22/99 Social Support May Extend Life Of People With Schizophrenia Treating Depression, Anxiety, Alcohol Abuse Significantly Reduces Teen Suicide Risk Vision Problems, Not Confusion, Cause Alzheimer's Patients To Become Lost 03/18/99 Newer Antidepressant Drugs As Effective As Older-Generation Treatments 03/16/99 AAGP MEETING: Seroquel Effective At Treating Psychosis In Patients With Alzheimer's, Parkinson's Cognitive-Behaviour Therapy And Drug Treatments Effective In Treating Late-Life Insomnia 03/12/99 Effexor XR Approved In The U.S. For Anxiety XANAX PLACEBO Low High Low High Hematology Hematocrit * * * * Hemoglobin * * * * Total WBC Count 1.4 2.3 1.0 2.0 Neutrophic Count 2.3 3.0 4.2 1.7 Lymphocyte Count 5.5 7.4 5.4 9.5 Monocyte Count 5.3 2.8 6.4 * Eosinophil Count 3.2 9.5 3.3 7.2 Basophil Count * * * * Urinalysis Albumin - * - * Sugar - * - * RBD/HPF - 3.4 - 5.0 WBC/HPF - 25.7 - 25.9 Blood Chemistry Creatinine 2.2 1.9 3.5 1.0 Bilirubin * 1.6 * * SGOT * 3.2 1.0 1.8 Alkaline Phosphatase * 1.7 * 1.8 Note: * Less than 1% 03/10/99 Epilepsy Drug Lamictal Appears Effective For Bipolar Depression 03/08/99 Viagra Not A Cure For All Sexual Problems, Researchers Says 03/05/99 Depression Linked To Reduced Blood Pressure Control Exelon Effective For Mild To Moderate Alzheimer's 03/04/99 Memantine Effective For Patients With Severe Dementia 03/01/99 Continued Treatment With Prozac Reduces Panic Attack Frequency 02/15/99 Lower Serotonin Levels Linked To Relapses In Bulimia Nervosa Most Patients With Obsessive-Compulsive Disorder Improve After Several Decades 02/11/99 Adding Natural Hormone Boosts Brain Function In Hypothyroidism 02/10/99 Celexa Approved In Canada For Treatment Of Depression 02/05/99 No Relationship Between Dental Amalgam And Alzheimer's Disease 01/29/99 Depression Linked To Higher Death Risk Women At Greater Risk Of Depression After Heart Attack 01/08/99 Frequent Digestion Complaints May Point To Psychiatric Disorders Research Shows No Link Between Mononucleosis And Depression 01/05/99 Psychotherapy And Nortriptyline Effective For Recurrent Depression In Elderly 01/04/99 Risk Of Schizophrenia Onset Linked To Brain Abnormalities 12/16/98 ACN MEETING: Seroquel More Effective Than Risperidone In Minimising EPS ACN MEETING: Seroquel Shown To Be Effective For Alzheimer's, Parkinson's 12/15/98 ACN MEETING: Zyprexa Reduces Behavioural, Psychiatric Symptoms Related To Alzheimer's Behavioural Therapy Effective In Treating Urinary Incontinence Risperdal Reduces Dementia And Other Psychoses In Elderly Patients XANAX Tablets are available as follows: 0.25 mg (white, oval, scored) Bottles of 100 NDC 0009-0029-01 Reverse Numbered Unit Dose (100) NDC 0009-0029-46 Bottles of 500 NDC 0009-0029-02 Bottles of 1000 NDC 0009-0029-14 0.5 mg (peach, oval, scored) Bottles of 100 NDC 0009-0055-01 Reverse Numbered Unit Doses (100) NDC 0009-0055-46 Bottles of 500 NDC 0009-0055-03 Bottles of 1000 NDC 0009-0055-15 1 mg (blue, oval, scored) Bottles of 100 NDC 0009-0090-01 Reverse Numbered Unit Dose (100) NDC 0009-0090-46 Bottles of 500 NDC 0009-0090-04 Bottles of 1000 NDC 0009-0090-13 2 mg (white, oblong, multi-scored) Bottles of 100 NDC 0009-0094-01 Bottles of 500 NDC 0009-0094-03 12/11/98 One-Third Of Children In Road Traffic Accidents Develop Stress Disorder 12/04/98 Researchers Find New Indicators For Alzheimer's Disease 11/24/98 Five Top Warning Signals Of Depression Identified Sertraline Found Safe And Effective For Obsessive-Compulsive Disorder In Children Tacrine Slows Cognitive Deterioration For Alzheimer's Patients 11/23/98 Childhood Loss Linked To Later Health Problems 11/17/98 Sertraline Beneficial For Ongoing Treatment Of Chronic Depression 11/16/98 Study Shows Prozac Can Reduce Symptoms Of Panic Disorder 11/10/98 Chronic Stress Puts Heart Disease Patients At Greater Risk 11/03/98 Remeron More Effective, Faster Working Than Cipramil or Paxil, Study Shows 10/30/98 Evidence Of Brain Injury In Ecstasy Users Olanzapine More Tolerable, As Effective As Clozaril For Treatment-Resistant Patients 10/29/98 Serious Crime Victims Risk PTSD, Multiple Disorders 10/28/98 Treatment of Depression May Help Reduce Mortality In Older Women 10/22/98 Older Adults' Speech-Processing Difficulties May Stem From Fast, Noisy Talk, Not Deafness Prenatal Cocaine Exposure Leads To Lower IQ Scores, Language Skills 10/20/98 Elevated Homocysteine Levels May Be Possible Risk Factor For Alzheimer Disease 10/19/98 FDA Approves Versed Syrup For Pediatric Pre-Operative Sedation 10/15/98 Altered Brain Chemistry In Bulimia Nervosa Patients Persists After Recovery 10/08/98 Seroxat/Paxil Approved In UK For Social Anxiety Disorder "From morning till evening and on through the night we are floating upon processes and systems that we don't understand." ------Syndicate mailinglist-------------------- Syndicate network for media culture and media art information and archive: http://www.v2.nl/syndicate to unsubscribe, write to <syndicate-request@aec.at> in the body of the msg: unsubscribe your@email.adress